Article
Low MBOAT7 expression, a genetic risk for MASH, promotes a profibrotic pathway involving hepatocyte TAZ upregulation.
Hepatology (Baltimore, Md.) - 1 Feb 2025
Moore Mary P, Wang Xiaobo, Kennelly John Paul, Shi Hongxue, Ishino Yuki, Kano Kuniyuki, Aoki Junken, Cherubini Alessandro, Ronzoni Luisa, Guo Xiuqing, Chalasani Naga P, Khalid Shareef, Saleheen Danish, Mitsche Matthew A, Rotter Jerome I, Yates Katherine P, Valenti Luca, Kono Nozomu, Tontonoz Peter, Tabas Ira
Abstract excerpt
BACKGROUND AND AIMS: The common genetic variant rs641738 C>T is a risk factor for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis (MASH), including liver fibrosis, and is associated with decreased expression of the phospholipid-remodeling enzyme MBOAT7 (LPIAT1). However, whether restoring MBOAT7 expression in established metabolic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
